ANI Pharmaceuticals, Inc. (ANIP) News & Overview - Discounting Cash Flows
ANIP
ANI Pharmaceuticals, Inc.
ANIP (NASDAQ)

ANIP's Business Model

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Sector & Industry Healthcare / Drug Manufacturers - Specialty & Generic
Website https://www.anipharmaceuticals.com
CEO (Chief Executive Officer) Nikhil Lalwani
Number of Employees
IPO date May 5, 2000

ANIP Latest News

Contact
CountryUS
Address210 Main Street West
CityBaudette
StateMN
Phone218 634 3500
Zip Code56623
Other Identifiers
CIK0001023024
ISINUS00182C1036
CUSIP00182C103
Open65.2
Previous Close65.22
Volume98.5 Thou.
Average Volume368 Thou.
Day’s Range63.74 – 65.72
52 Week Range52.5-77
MA (50)64.2942
MA (200)60.69395
Market Cap1.41 Bil.
Shares Out.21.65 Mil.
Earnings DateAug 04, 2025
Beta
Last Dividend
EPS
PE

Industry Competitors for ANIP

discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us